Literature DB >> 16829947

Alzheimer disease: progress or profit?

Claire Mount1, Christian Downton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16829947     DOI： 10.1038/nm0706-780

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  67 in total

1.  Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats.

Authors:  Gao-Shang Chai; Dong-Xiao Duan; Rong-Hong Ma; Jian-Ying Shen; Hong-Lian Li; Zhi-Wei Ma; Yu Luo; Lu Wang; Xin-Hua Qi; Qun Wang; Jian-Zhi Wang; Zelan Wei; Darrell D Mousseau; Li Wang; Gongping Liu
Journal:  Neurosci Bull       Date:  2014-11-12       Impact factor: 5.203

2.  Fragment-guided approach to incorporating structural information into a CoMFA study: BACE-1 as an example.

Authors:  Lívia Barros Salum; Napoleão Fonseca Valadares
Journal:  J Comput Aided Mol Des       Date:  2010-07-27       Impact factor: 3.686

3.  Drugs for Alzheimer's disease: are they effective?

Authors:  David A Casey; Demetra Antimisiaris; James O'Brien
Journal:  P T       Date:  2010-04

Review 4.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

Review 5.  Substrate specificity of gamma-secretase and other intramembrane proteases.

Authors:  A J Beel; C R Sanders
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

6.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

Review 7.  A brief history of the development of antidepressant drugs: from monoamines to glutamate.

Authors:  Todd M Hillhouse; Joseph H Porter
Journal:  Exp Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.157

8.  Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function.

Authors:  Katherine Ab Kellett; Jonathan Williams; Emma Rlc Vardy; A David Smith; Nigel M Hooper
Journal:  Int J Mol Epidemiol Genet       Date:  2011-02-10

9.  Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease.

Authors:  Nanthia A Suthana; Allison Krupa; Markus Donix; Alison Burggren; Arne D Ekstrom; Michael Jones; Linda M Ercoli; Karen J Miller; Prabha Siddarth; Gary W Small; Susan Y Bookheimer
Journal:  Neuroimage       Date:  2009-12-18       Impact factor: 6.556

10.  Geographical differences in the occurrence of Alzheimer's disease mortality: United States versus Puerto Rico.

Authors:  Raul Figueroa; Kyle Steenland; Jessica R MacNeil; Allan I Levey; Irving E Vega
Journal:  Am J Alzheimers Dis Other Demen       Date:  2008 Oct-Nov       Impact factor: 2.035
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.